Scheinberg M A, Cathcart E S
Clin Exp Immunol. 1976 May;24(2):317-22.
Antibody-dependent direct cytotoxicity (ADDC) is generally believed to be unrelated to T-cell function in experimental animals. The role of ADDC in humans and its clinical usefulesss was evaluated in patients with systemic lupus erythematosus (SLE) and normal controls. Peripheral blood lymphocytes from patients with active SLE were unable to lyse antibody-coated target cells in vitro to the same degree as lymphocytes from patients with inactive SLE and controls. Sera from patients with active SLE suppressed ADDC by lymphocytes derived from normal controls and this abnormality was not corrected by overnight incubation or by extensive washing of lymphocyte preparations. Although there was poor correlation between ADDC and the proportions of B cells and null cells in effector lymphocyte populations from SLE patients and controls, it is concluded that this assay provides another means of determining immune competence in man.
抗体依赖性直接细胞毒性(ADDC)通常被认为在实验动物中与T细胞功能无关。在系统性红斑狼疮(SLE)患者和正常对照中评估了ADDC在人类中的作用及其临床实用性。活动期SLE患者的外周血淋巴细胞在体外裂解抗体包被的靶细胞的能力不如非活动期SLE患者和对照的淋巴细胞。活动期SLE患者的血清抑制了正常对照来源的淋巴细胞的ADDC,并且这种异常不能通过过夜孵育或对淋巴细胞制剂进行大量洗涤来纠正。尽管SLE患者和对照的效应淋巴细胞群体中ADDC与B细胞和裸细胞的比例之间相关性较差,但得出的结论是,该检测方法为确定人类免疫能力提供了另一种手段。